Cameron Matthew, Cornelius Iwan, Cutajar Dean, Davis Jeremy, Rosenfeld Anatoly, Lerch Michael, Guatelli Susanna
CMRP, University of Wollongong, Wollongong, NSW 2522, Australia.
Australian Synchrotron, Melbourne, VIC 3168, Australia.
J Synchrotron Radiat. 2017 Jul 1;24(Pt 4):866-876. doi: 10.1107/S1600577517005641. Epub 2017 May 18.
Microbeam radiation therapy (MRT) is a promising radiotherapy modality that uses arrays of spatially fractionated micrometre-sized beams of synchrotron radiation to irradiate tumours. Routine dosimetry quality assurance (QA) prior to treatment is necessary to identify any changes in beam condition from the treatment plan, and is undertaken using solid homogeneous phantoms. Solid phantoms are designed for, and routinely used in, megavoltage X-ray beam radiation therapy. These solid phantoms are not necessarily designed to be water-equivalent at low X-ray energies, and therefore may not be suitable for MRT QA. This work quantitatively determines the most appropriate solid phantom to use in dosimetric MRT QA. Simulated dose profiles of various phantom materials were compared with those calculated in water under the same conditions. The phantoms under consideration were RMI457 Solid Water (Gammex-RMI, Middleton, WI, USA), Plastic Water (CIRS, Norfolk, VA, USA), Plastic Water DT (CIRS, Norfolk, VA, USA), PAGAT (CIRS, Norfolk, VA, USA), RW3 Solid Phantom (PTW Freiburg, Freiburg, Germany), PMMA, Virtual Water (Med-Cal, Verona, WI, USA) and Perspex. RMI457 Solid Water and Virtual Water were found to be the best approximations for water in MRT dosimetry (within ±3% deviation in peak and 6% in valley). RW3 and Plastic Water DT approximate the relative dose distribution in water (within ±3% deviation in the peak and 5% in the valley). PAGAT, PMMA, Perspex and Plastic Water are not recommended to be used as phantoms for MRT QA, due to dosimetric discrepancies greater than 5%.
微束放射治疗(MRT)是一种很有前景的放射治疗方式,它使用同步加速器辐射的微米级空间分割束阵列来照射肿瘤。治疗前进行常规剂量测定质量保证(QA)对于识别治疗计划中束条件的任何变化是必要的,并且使用固体均匀模体来进行。固体模体是为兆伏级X射线束放射治疗设计并常规使用的。这些固体模体不一定设计为在低X射线能量下与水等效,因此可能不适用于MRT质量保证。这项工作定量地确定了用于剂量测定MRT质量保证的最合适的固体模体。将各种模体材料的模拟剂量分布与在相同条件下在水中计算的剂量分布进行了比较。所考虑的模体有RMI457固体水(美国威斯康星州米德尔顿的Gammex-RMI公司)、塑料水(美国弗吉尼亚州诺福克的CIRS公司)、塑料水DT(美国弗吉尼亚州诺福克的CIRS公司)、PAGAT(美国弗吉尼亚州诺福克的CIRS公司)、RW3固体模体(德国弗莱堡的PTW弗莱堡公司)、聚甲基丙烯酸甲酯、虚拟水(美国威斯康星州维罗纳的Med-Cal公司)和有机玻璃。发现RMI457固体水和虚拟水在MRT剂量测定中是最接近水的(峰值偏差在±3%以内,谷值偏差在6%以内)。RW3和塑料水DT近似水中的相对剂量分布(峰值偏差在±3%以内,谷值偏差在5%以内)。由于剂量测定差异大于5%,不建议将PAGAT、聚甲基丙烯酸甲酯、有机玻璃和塑料水用作MRT质量保证的模体。